» Articles » PMID: 30557368

Assessment of Degenerative Cervical Myelopathy Differs Between Specialists and May Influence Time to Diagnosis and Clinical Outcomes

Overview
Journal PLoS One
Date 2018 Dec 18
PMID 30557368
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Degenerative Cervical Myelopathy [DCM] often presents with non-specific symptoms and signs. It progresses insidiously and leads to permanent neurological dysfunction. Decompressive surgery can halt disease progression, however significant delays in diagnosis result in increased disability and limit recovery. The nature of early DCM symptoms is unknown, moreover it has been suggested incomplete examination contributes to missed diagnosis. This study examines how DCM is currently assessed, if assessment differs between stages of healthcare, and whether this influences patient management.

Study Design: Retrospective cohort study.

Methods: Cervical MRI scans (N = 1123) at a tertiary neurosciences center, over a single year, were screened for patients with DCM (N = 43). Signs, symptoms, and disease severity of DCM were extracted from patient records. Patients were considered at 3 phases of clinical assessment: primary care, secondary care, and surgical assessment.

Results: Upper limb paraesthesia and urinary dysfunction were consistently the most and least prevalent symptoms respectively. Differences between assessing clinicians were present in the reporting of: limb pain (p<0.005), objective limb weakness (p = 0.01), hyperreflexia (p<0.005), Hoffmann reflex (p<0.005), extensor plantar reflex (p = 0.007), and lower limb spasticity (p<0.005). Pathological reflexes were least frequently assessed by primary care doctors.

Conclusion: DCM assessment varies significantly between assessors. Reporting of key features of DCM is especially low in primary care. Incomplete assessment may hinder early diagnosis and referral to spinal surgery.

Citing Articles

Outcomes for Degenerative Cervical Myelopathy Following Implementation of the AO Spine International Guidelines: A Single-Centre Service Evaluation.

Brannigan J, Vellaiyappan S, Mowforth O, Magee J, Francis J, Davies B Global Spine J. 2024; :21925682241301049.

PMID: 39523024 PMC: 11561916. DOI: 10.1177/21925682241301049.


Degenerative Cervical Myelopathy Awareness in Primary Care: UK National Cross-Sectional Survey of General Practitioners.

Rufus-Toye R, Rafati Fard A, Mowforth O, McCarron L, Chan K, Hirayama Y JMIR Form Res. 2024; 8:e58802.

PMID: 39158957 PMC: 11369528. DOI: 10.2196/58802.


The significance of metabolic disease in degenerative cervical myelopathy: a systematic review.

Partha Sarathi C, Sinha A, Rafati Fard A, Bhatti F, Rujeedawa T, Ahmed S Front Neurol. 2024; 15:1301003.

PMID: 38375465 PMC: 10876002. DOI: 10.3389/fneur.2024.1301003.


Management of mild degenerative cervical myelopathy and asymptomatic spinal cord compression: an international survey.

Brannigan J, Davies B, Mowforth O, Yurac R, Kumar V, Dejaegher J Spinal Cord. 2023; 62(2):51-58.

PMID: 38129661 PMC: 10853067. DOI: 10.1038/s41393-023-00945-8.


The information needs of people with degenerative cervical myelopathy: A qualitative study to inform patient education in clinical practice.

Sangeorzan I, Andriopoulou P, Davies B, McNair A PLoS One. 2023; 18(5):e0285334.

PMID: 37205664 PMC: 10198551. DOI: 10.1371/journal.pone.0285334.


References
1.
Nicholl D, Appleton J . Clinical neurology: why this still matters in the 21st century. J Neurol Neurosurg Psychiatry. 2014; 86(2):229-33. PMC: 4316836. DOI: 10.1136/jnnp-2013-306881. View

2.
Kovalova I, Kerkovsky M, Kadanka Z, Kadanka Jr Z, Nemec M, Jurova B . Prevalence and Imaging Characteristics of Nonmyelopathic and Myelopathic Spondylotic Cervical Cord Compression. Spine (Phila Pa 1976). 2016; 41(24):1908-1916. DOI: 10.1097/BRS.0000000000001842. View

3.
Vilaca C, Orsini M, Araujo Leite M, de Freitas M, Davidovich E, Fiorelli R . Cervical Spondylotic Myelopathy: What the Neurologist Should Know. Neurol Int. 2016; 8(4):6330. PMC: 5136752. DOI: 10.4081/ni.2016.6330. View

4.
Kadanka Jr Z, Adamova B, Kerkovsky M, Kadanka Z, Dusek L, Jurova B . Predictors of symptomatic myelopathy in degenerative cervical spinal cord compression. Brain Behav. 2017; 7(9):e00797. PMC: 5607559. DOI: 10.1002/brb3.797. View

5.
Davies B, Mowforth O, Smith E, Kotter M . Degenerative cervical myelopathy. BMJ. 2018; 360:k186. PMC: 6074604. DOI: 10.1136/bmj.k186. View